James R. Jones's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 18 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on Dec. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 18 | 44,811 (0%) | 0% | 2.3 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 18 | 44,883 (0%) | 0% | 2.3 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 18 | 44,865 (0%) | 0% | 2.3 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 18 | 44,847 (0%) | 0% | 2.3 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 18 | 44,829 (0%) | 0% | 2.2 | 40 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 14 | 44,981 (0%) | 0% | 3.3 | 46 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 14 | 44,967 (0%) | 0% | 2.8 | 39 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 14 | 44,953 (0%) | 0% | 2.5 | 35 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 14 | 44,939 (0%) | 0% | 2.6 | 36 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 14 | 44,925 (0%) | 0% | 2.6 | 36 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 14 | 44,911 (0%) | 0% | 2.3 | 32 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 14 | 44,897 (0%) | 0% | 2.4 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 10 | 45,001 (0%) | 0% | 4.2 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 10 | 44,991 (0%) | 0% | 3.7 | 37 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 8 | 45,056 (0%) | 0% | 4 | 32 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 8 | 45,048 (0%) | 0% | 4 | 32 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 8 | 45,040 (0%) | 0% | 4.3 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 8 | 45,032 (0%) | 0% | 4.3 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 8 | 45,024 (0%) | 0% | 4.1 | 33 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 8 | 45,009 (0%) | 0% | 4.3 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 7 | 45,063 (0%) | 0% | 3.9 | 27 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Dec 2025 | 7 | 45,016 (0%) | 0% | 4.3 | 30 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 18 | 44,793 (0%) | 0% | 2.4 | 43 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 18 | 44,775 (0%) | 0% | 2.2 | 39 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 18 | 44,757 (0%) | 0% | 2.2 | 40 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 18 | 44,739 (0%) | 0% | 2.1 | 38 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 17 | 44,721 (0%) | 0% | 1.9 | 33 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 17 | 44,704 (0%) | 0% | 2 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 17 | 44,687 (0%) | 0% | 2 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 17 | 44,670 (0%) | 0% | 2 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 17 | 44,653 (0%) | 0% | 2.2 | 37 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 16 | 44,636 (0%) | 0% | 2.1 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 16 | 44,620 (0%) | 0% | 2.2 | 35 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 16 | 44,604 (0%) | 0% | 2 | 32 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 16 | 44,588 (0%) | 0% | 2.1 | 33 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 16 | 44,572 (0%) | 0% | 2.1 | 34 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 13 | 44,530 (0%) | 0% | 2.5 | 33 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 13 | 44,504 (0%) | 0% | 2.8 | 36 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 13 | 44,556 (0%) | 0% | 2.2 | 28 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 13 | 44,543 (0%) | 0% | 2.3 | 30 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 03 Nov 2025 | 13 | 44,517 (0%) | 0% | 2.8 | 37 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,283 (0%) | 0% | 3.5 | 46 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,205 (0%) | 0% | 3.3 | 43 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,478 (0%) | 0% | 3.3 | 43 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,465 (0%) | 0% | 3.2 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,452 (0%) | 0% | 3.3 | 43 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,439 (0%) | 0% | 3.5 | 45 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,426 (0%) | 0% | 3.5 | 46 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,413 (0%) | 0% | 3.5 | 45 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,400 (0%) | 0% | 3.6 | 47 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,387 (0%) | 0% | 3.6 | 47 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,374 (0%) | 0% | 3.5 | 46 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,491 (0%) | 0% | 3.4 | 44 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,361 (0%) | 0% | 3.5 | 45 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,348 (0%) | 0% | 3.5 | 45 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,335 (0%) | 0% | 3.4 | 44 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,322 (0%) | 0% | 3.4 | 44 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,309 (0%) | 0% | 3.5 | 46 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,296 (0%) | 0% | 3.6 | 47 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,218 (0%) | 0% | 3.3 | 43 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,270 (0%) | 0% | 3.6 | 47 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,257 (0%) | 0% | 3.2 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,244 (0%) | 0% | 3.2 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 01 Oct 2025 | 13 | 44,231 (0%) | 0% | 3.2 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 13 | 44,192 (0%) | 0% | 3.2 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 13 | 44,179 (0%) | 0% | 3.2 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,106 (0%) | 0% | 3.3 | 40 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 43,962 (0%) | 0% | 3.6 | 43 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 43,974 (0%) | 0% | 3.6 | 43 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 43,986 (0%) | 0% | 3.6 | 43 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 43,998 (0%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,010 (0%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,022 (0%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,034 (0%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,046 (0%) | 0% | 3.5 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,058 (0%) | 0% | 3.5 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,070 (0%) | 0% | 3.5 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,082 (0%) | 0% | 3.4 | 41 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,094 (0%) | 0% | 3.3 | 40 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,118 (0%) | 0% | 3.3 | 39 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,130 (0%) | 0% | 3.3 | 39 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,142 (0%) | 0% | 3.1 | 37 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,154 (0%) | 0% | 3.1 | 37 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 44,166 (0%) | 0% | 3.1 | 37 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | 02 Sep 2025 | 12 | 43,950 (0%) | 0% | 3.5 | 42 | Common Stock | |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 01 Aug 2025 | 13 | 43,938 (0%) | 0% | 3.5 | 45 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 01 Aug 2025 | 13 | 43,702 (0%) | 0% | 4 | 52 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.92 per share. | 01 Aug 2025 | 13 | 43,715 (0%) | 0% | 3.9 | 51 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 01 Aug 2025 | 13 | 43,728 (0%) | 0% | 3.3 | 43 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 01 Aug 2025 | 13 | 43,741 (0%) | 0% | 3.2 | 41 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 01 Aug 2025 | 13 | 43,754 (0%) | 0% | 3.4 | 44 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 01 Aug 2025 | 13 | 43,767 (0%) | 0% | 2.8 | 37 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 01 Aug 2025 | 13 | 43,780 (0%) | 0% | 2.9 | 38 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 01 Aug 2025 | 13 | 43,793 (0%) | 0% | 2.9 | 38 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 01 Aug 2025 | 13 | 43,806 (0%) | 0% | 2.8 | 37 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 01 Aug 2025 | 13 | 43,819 (0%) | 0% | 3 | 39 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 01 Aug 2025 | 13 | 43,832 (0%) | 0% | 3.1 | 40 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 01 Aug 2025 | 13 | 43,845 (0%) | 0% | 3.2 | 42 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 01 Aug 2025 | 13 | 43,860 (0%) | 0% | 3.2 | 42 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 01 Aug 2025 | 13 | 43,873 (0%) | 0% | 3.3 | 43 | Common Stock |
| Cumberland Pharma Inc | James R. Jones | Director | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 01 Aug 2025 | 13 | 43,886 (0%) | 0% | 3.3 | 43 | Common Stock |